An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Top results in this bookTable of Contents
Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease.
National Clinical Guideline Centre (UK).
London: Royal College of Physicians (UK); 2012 Aug. (NICE Clinical Guidelines, No. 148.)
Suspected neurological conditions: recognition and referral.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2019 May. (NICE Guideline, No. 127.)
Cerebral palsy in under 25s: assessment and management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2017 Jan. (NICE Guideline, No. 62.)
WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents.
Geneva: World Health Organization; 2018.
Special Topics in Venous Thromboembolism [Internet].
Grant PJ, Courey AJ, Hanigan S, et al.
Ann Arbor (MI): Michigan Medicine University of Michigan; 2019 Feb.
Spinal Injury: Assessment and Initial Management.
London: National Institute for Health and Care Excellence (NICE); 2016 Feb. (NICE Guideline, No. 41.)
CADTH Canadian Drug Expert Committee Recommendation: Ocrelizumab (Ocrevus ‒ Hoffmann-La Roche Limited): Indication: Management of adult patients with early primary progressive multiple sclerosis (PPMS) as defined by disease duration and level of disability, in conjunction with imaging features characteristic of inflammatory activity [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr 30.
Thyroid cancer: assessment and management.
London: National Institute for Health and Care Excellence (NICE); 2022 Dec 19. (NICE Guideline, No. 230.)
Global Guidelines for the Prevention of Surgical Site Infection.
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2010 Jul. (NICE Clinical Guidelines, No. 104.)
Regulatory Processes for Rare Disease Drugs in the United States and European Union: Flexibilities and Collaborative Opportunities.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Processes to Evaluate the Safety and Efficacy of Drugs for Rare Diseases or Conditions in the United States and the European Union; Shore CK, Worku TL, Smith CW, et al., editors.
Washington (DC): National Academies Press (US); 2024 Oct 30.
WHO guidelines on management of Taenia solium neurocysticercosis [Internet].
Geneva: World Health Organization; 2021.
Spinal metastases and metastatic spinal cord compression.
London: National Institute for Health and Care Excellence (NICE); 2023 Sep 6. (NICE Clinical Guidelines, No. 234.)
Non-Hodgkin's Lymphoma: Diagnosis and Management.
London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 52.)
Comprehensive Cervical Cancer Control: A Guide to Essential Practice. 2nd edition.
Geneva: World Health Organization; 2014.
Cancer Control: Knowledge Into Action: WHO Guide for Effective Programmes: Module 4: Diagnosis and Treatment.
Geneva: World Health Organization; 2008.
WHO Guidelines for Indoor Air Quality: Selected Pollutants.
Geneva: World Health Organization; 2010.
Cabozantinib (Cabometyx): CADTH Reimbursement Recommendation: Indication: Cabozantinib, in combination with nivolumab, is indicated for the first-line treatment of adult patients with advanced (not amenable to curative surgery or radiation therapy) or metastatic renal cell carcinoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.
Nelarabine (Atriance): CADTH Reimbursement Recommendation: Indication: Nelarabine (Atriance) for addition to front-line multiagent therapy of pediatric, adolescent, and young adult patients (aged 1 year to 30 years at diagnosis) with intermediate- or high-risk T-cell acute lymphoblastic leukemia [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Oct.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on